Press Releases

In the News

ImmunogenX (50 Best Companies to Watch 2018: May 2018)

Dr. Jennifer Sealey Voyksner and Dr. Jack Syage speak at National Conference (Celiac Disease Foundation: May 5th, 2018)

The Dilemma of the Gluten-Free Diet (Wall Street Journal: April 16th, 2018)

When Going Gluten-Free Is Not Enough: New Tests Detect Hidden Exposure (NPR: April 3rd, 2018)

Gluten-Free Diet May Still Allow Harmful Levels of Exposure (Reuters: March 21st, 2018)

Celiac Disease Patients are Regularly Exposed to Unsafe Amounts of Gluten, Study Shows (Beyond Celiac: March 15, 2018)

Significant Study Published on the Amount of Gluten Eaten by Folks with Celiac Disease on a Gluten-Free Diet (Gluten-Free Watchdog: March 12, 2018)

Breaking Down Gluten to Treat Celiac Disease (Beyond Celiac: November 28th, 2017) 

ImmunogenX Executives Interviewed (New York Stock Exchange: August 30th, 2017) 

Update on Celiac Drug Designed to Support the Gluten-Free Diet (Allergic Living: July 26th, 2017) 

Events

2022

19th International Celiac Disease Symposium (ICDS), October 19-22, 2022, Sorrento, Italy

  • J. A. Syage, “Enzyme Therapy” (Invited Talk and Panel Discussion)
  • J. A. Sealey-Voyksner, et al.: “Gluten in Urine Measurements Validate Latiglutenase Mechanism of Action in CeliacShield Gluten Challenge Study” (Poster)
  • J. A. Syage, et al. “Considerations for a Composite Quantitative Histology Scale Based on Vh:Cd and IEL” (Poster)

BIO International Convention, June 13-16, San Diego, CA

  • Jack Syage, “Breakthrough Treatments for Celiac Disease” (Invited Presentation)

Digestive Diseases Week (DDW), May 21-24 San Diego, CA

  • J.A. Murray (Mayo), J. A. Syage, et al.: “CeliacShieldTM Gluten Challenge Study – Latiglutenase Protects the Mucosa and Attenuates Symptoms of Celiac Disease” (Invited Lecture Presentation)
  • J. A. Sealey-Voyksner, et al.: “Gluten in Urine Measurements Validate Latiglutenase Mechanism of Action in CeliacShield Gluten Challenge Study” (Poster of Distinction and Poster Tour)

Celiac Disease, Where are the Patients and the Therapies?, April 8-9, 2022, Columbia University, NY

  • Jennifer Sealey-Voyksner: CeliacShieldTM Gluten Challenge Study” (Invited Talk)
2021

Life Sciences Summit 2021, Sponsored by the NIH, November 9-10, 2021

  • Jack Syage, “Breakthrough Treatments for Celiac Disease,” (Invited Presentation)

United European Gastroenterology (UEG) Week Virtual 2021, October 3-5, 2021

  • Jennifer Sealey-Voyksner, “CeliacShieldTM Gluten Challenge Study: Latiglutenase Protects the Mucosa and Attenuates Symptoms in Celiac Disease Patients” (Invited talk – UEG Research Prize 2021 Session)

19th International Celiac Disease Symposium (ICDS), October 14-17, 2021, Sorrento, Italy

  • Jack Syage, “Title: TBD” (Distinguished Speaker)

Celiac Disease Foundation Patient Education & Advocacy Summit, March 4, 2021

  • Jennifer Sealey-Voyksner, “Current State of Celiac Disease Diagnosis, Treatment, and Clinical Research” (Chair)

Tampere Celiac Disease Symposium 2020 – From Genomics to Personalized Health, September 18-19, 2020, Tampere University, Tampere, Finland

  • J. A. Syage, et al.: Latest Latiglutenase Clinical Trial Updates”
  • J. Sealey-Voyksner, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients”

International Symposium – Celiac Disease, Now and the Future, March 6-7, 2020, Columbia University, NY

  • Jack A. Syage: Enzymes are Still in the Picture: the Case for Latiglutenase” (Invited Talk)
  • Jennifer A. Sealey-Voyksner: Gluten Detection in Food” (Invited Talk)

Celiac Disease Foundation Patient Advocacy Summit, February 27, 2020, Washington, CD

  • Jack A. Syage: Today and Tomorrow in Biopharmaceutical Research, Treatment and Cure” (Panel Talk)

Beyond Celiac Research Summit, November 14-15, 2019, Baltimore, MD

  • Jennifer Sealey-Voyksner: “Getting Over the Peak: The Final Ascent to Realizing Therapies in Celiac Disease.” (panel member)

18th International Celiac Disease Symposium (ICDS) Sept 5-8, 2019, Paris, France

  • J. A. Syage, P. H. R. Green, C. Khosla, D. C. Adelman, J. A. Sealey-Voyksner, J. A. Murray: “Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet”
  • J. A. Sealey-Voyksner, J. A. Murray, C. Khosla, J. A. Syage: “Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients”

IV International Conference on Urinomics and Translational Nephrology Sept 2-4, 2019, Caparica, Portugal

  • J. A. Syage, C. P. Kelly, A. C. Cebolla Ramirez, F. Leon, R. Dominguez, J. A. Sealey-Voyksner: “Determination of Gluten Consumption in Celiac Disease Patients on a Gluten-Free Diet” (invited talk)

Digestive Diseases Week (DDW), May 18-22, San Diego, CA

  • J. A. Syage, et al.: Responder Analysis for Latiglutenase Reduction in Symptoms for Celiac Disease Patients” 
  • J. A. Sealey-Voyksner, et al.: Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients”
  • J.A. Syage, et al.: Latiglutenase Improves Quality of Life in Seropositive Celiac Disease Patients
  • A. C. Bledsoe, et al.: “Utility of Symptom Severity, Frequency, and Lability in Predicting Serology Status and Villous Injury in Symptomatic Adults with Treated Celiac Disease”

Tampere Celiac Disease Symposium 2018 – Serology and Biomarkers, September 13-15, 2018, University of Tampere, Tampere, Finland

  • J. A. Syage, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients” (talk)
  • J. A. Sealey-Voyksner, et al.: Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet” (poster)
  • J. A. Syage, et al.: Correlation of Histologic and Symptomatic Response in a Celiac Trial for Latiglutenase” (poster)

Digestive Diseases Week (DDW), June 2-5, Washington, DC

  • J. A. Syage, et al.: Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet” 
  • J. A. Sealey-Voyksner, et al.: Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients
  • J.A. Syage, et al.: Correlation of Histologic, Serologic, and Symptomatic Measures of Celiac Disease Patients Participating in a Latiglutenase Clinical Trial

Celiac Disease Foundation National Conference – Progress and Promise in the Treatment of Celiac Disease, May 4-5, 2018, Pasadena, CA

  • Jennifer A. Sealey-Voyksner: Living Gluten-Free to Live” (invited talk)
  • Jack A. Syage: Progress and Promise in the Treatment of Celiac Disease” (invited talk)

International Symposium – Celiac Disease, Now and the Future, March 1-3, 2018, Columbia University, NY

  • Jack A. Syage: Latiglutenase Really Works!” (invited talk)
  • Jennifer A. Sealey-Voyksner: Skip the ELISA: Liquid Chromatography-Mass Spectrometry” (invited talk)

Celiac Symposium, Nov 17, 2017, Stanford, CA

  • J. Sealey-Voyksner: Non-Dietary Therapies for Celiac Disease” (invited talk)

American Association of Pharmaceutical Scientists (AAPS) Nov 12-15, 2017, San Diego, CA

  • J. Sealey-Voyksner, J. Murray, C. Khosla, J. Syage: Monitoring Simvastatin Metabolism using LC/MS as a Diagnostic Tool for Celiac Disease Activity

17th International Celiac Disease Symposium (ICDS) Sept 8-10, 2017, New Delhi, India

  • J. A. Syage, J. A. Murray, Peter H. R. Green, J. A. Sealey-Voyksner, C. Khosla: Latiglutenase Symptom Response for Seropositive vs. Seronegative Celiac Disease Patients (talk)
  • J. A. Sealey-Voyksner, J. A. Murray, M. Dickason, C. Khosla, J. A. Syage: Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients (talk)
  • J. A. Syage, , P. T. Lavin, J. A. Sealey-Voyksner Relationship Between Gluten Consumption and Symptom Severity for Celiac Disease Patients on a Gluten-Free Diet (poster)

American Society of Mass Spectrometry (ASMS) Annual Meeting, June 4-8, 2017, Indianapolis, IN

  • J. A. Sealey-Voyksner, J. A. Syage, J. A. Murray, C. Khosla: Monitoring Simvastatin Metabolism using LC/MS as a Diagnostic Tool for Celiac Disease Activity

Digestive Diseases Week (DDW), May 6-9, 2017, Chicago, IL

  • Jack A. Syage: Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients” (Lecture Presentation)
  • J. A. Syage, M. A. Dickason, J. A. Sealey-Voyksner: “Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten”

Biotech Showcase, Jan 9-11, 2017, San Francisco, CA

  • Jack A. Syage: Advanced Therapy and Diagnostic to Manage Celiac Disease” 

Medical Devices Investment Forum, Oct 28, 2016, Newport Beach, CA

  • Jack A. Syage: “Advanced Therapy and Diagnostic to Manage Celiac Disease” (invited talk)

Pharmaceutical Strategy Conference, Sept 28-30, 2016, New York, NY

  • Jack A. Syage: “The Novel Use of Proprietary Enzymes for the Treatment of Celiac Disease” (invited talk)

AOAC Annual Meeting, Sept 18-21, 2016, Dallas, TX

  • JA Sealey-Voyksner: “Towards a validated multiplexed LC-MS method for the detection of allergens and gluten in processed, fermented, hydrolyzed and distilled foods” (invited talk)

AOAC Annual Meeting, Sept. 27-30, 2015, Los Angeles, CA

  • JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: Authenticity of Spice: Detection and Quantitation of Allergens
  • JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: Discovery of Unique Marker Peptides for Effective Detection of Soy and Wheat in Soy Sauce

NACRW, July 19-22, 2015, St. Pete Beach, FL

  • JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: Authenticity of Spice using LC/MS

DDW 2015, May 16-19, Washington, DC

  • S Nazareth, B Lebwohl, JA Sealey Voyksner and PHR Green: Widespread Contamination of Probiotics with Gluten, Detected with Liquid Chromatography/Mass Spectrometry

ASMS Annual Meeting, May 31-June 4, 2015, St. Louis, MO

MSACL 2015 Clinical Mass Spectrometry Conference, March 28-April 1, 2015, San Diego, CA

30th Montreux LC/MS Symposium – Food Allergens and Safety, Nov. 5-7, 2014, Charleston, SC, USA

  • JA Syage, JA Sealey-Voyksner, C Khosla: Metabolic Diagnostic for Celiac Disease Dietary Management by LC/MS (invited talk)
  • JA Sealey-Voyksner: Multiplexed LC-MS assay for green plant-based allergens
  • ImmunogenX – Silver Sponsor

AACC International Annual Meeting, October 5-8, Providence, RI

  • JA Sealey-Voyksner: Gluten Detection and Quantitation in Food and Beverages Using a Multiplexed LC-MS Screening Method Based on Grain Specific Marker Peptides (invited talk)

Separation Science Webinar – Advances in Food Safety Analysis, Sept 23, 2014

  • JA Sealey-Voyksner: Multiplexed LC-MS Screening Method for the Simultaneous Detection of Various Plant-Based Allergens and Gluten (invited talk)

AOAC Annual Meeting, Sept. 7-10, 2014, Boca Raton, FL

  • JA Sealey-Voyksner: Qualitative and Quantitative Detection of Wheat, Barley and Rye Gluten in Beer by LC-MS (invited talk)
  • JA Sealey-Voyksner: “Towards the Validation of a new LC-MS Screening Method for the Simultaneous Detection and Quantitation of Multiple Plant-Based Allergens (invited talk)
  • JA Sealey-Voyksner: “The Discovery of Unique Marker Peptides for Detection of Trace Levels of Soy in Food Using LC/MS

NACRW Annual Meeting, July 21-23, 2014, St. Pete, FL

  • JA Sealey-Voyksner: Moving Food Safety to Peptides- New Approaches using LC-MS for the Detection of Plant Allergens

ASMS Annual Meeting, June 15-19, 2014, Baltimore, MD

  • JA Sealey-Voyksner: Simultaneous Screening of Multiple Plant-based Allergens and Gluten using Liquid Chromatography-Mass Spectrometry

AOAC 33rd Annual Midwest Meeting, June 2-5, 2014, Oak Brook, IL

  • JA Sealey-Voyksner: “LC-MS Screening Method for Multiple Plant-Based Allergens and Gluten (invited talk)

8th Workshop on Food Allergens Methodologies, May 7, 2014, Vancouver, BC, Canada

  • JA Sealey-Voyksner: LC-MS Screening Method for Multiple Plant-Based Allergens and Gluten (invited talk)
  • JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Wheat, Barley and Rye Gluten in Beer by LC-MS”

NASSCD: Therapies for Celiac Disease Conference, Mar. 20-21, 2014, Columbia University, NY

  • JA Sealey-Voyksner: “Gluten Detection in the Food Chain” (invited talk)

MSACL 2014 Clinical Mass Spectrometry Conference, Mar. 1-5, 2014, San Diego, CA

  • JA Syage, J Sealey-Voyksner, C. Khosla: Non-invasive, in-situ screen for celiac disease management
  • JA Sealey-Voyksner: Qualitative and Quantitative Detection of Plant-based allergens by LC-MS